Arrowstreet Capital Limited Partnership Reduces Position in Globe Life Inc. $GL

Arrowstreet Capital Limited Partnership decreased its holdings in Globe Life Inc. (NYSE:GL) by 5.3% in the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,122,736 shares of the company’s stock after selling 62,547 shares during the quarter. Arrowstreet Capital Limited Partnership owned 1.39% of Globe Life worth $139,545,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of GL. Quantbot Technologies LP bought a new stake in shares of Globe Life in the second quarter worth approximately $228,000. Norges Bank bought a new position in Globe Life during the second quarter valued at approximately $157,722,000. Northwestern Mutual Wealth Management Co. boosted its holdings in Globe Life by 80.1% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 2,345 shares of the company’s stock worth $291,000 after purchasing an additional 1,043 shares during the last quarter. Grantham Mayo Van Otterloo & Co. LLC purchased a new stake in Globe Life in the second quarter worth approximately $1,368,000. Finally, Employees Retirement System of Texas bought a new stake in Globe Life in the 2nd quarter worth approximately $85,000. Institutional investors own 81.61% of the company’s stock.

Globe Life Price Performance

NYSE GL opened at $131.12 on Wednesday. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.41. Globe Life Inc. has a 12 month low of $100.27 and a 12 month high of $147.83. The stock has a market cap of $10.44 billion, a price-to-earnings ratio of 9.50 and a beta of 0.48. The company’s 50 day moving average is $135.11 and its two-hundred day moving average is $131.86.

Globe Life (NYSE:GL) last announced its quarterly earnings data on Wednesday, October 22nd. The company reported $4.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.54 by $0.27. The firm had revenue of $1.51 billion during the quarter, compared to analysts’ expectations of $1.52 billion. Globe Life had a net margin of 19.36% and a return on equity of 21.81%. During the same period in the prior year, the company posted $3.44 earnings per share. Globe Life has set its FY 2026 guidance at 14.600-15.300 EPS and its FY 2025 guidance at 14.400-14.600 EPS. As a group, research analysts anticipate that Globe Life Inc. will post 13.87 earnings per share for the current year.

Globe Life Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Monday, January 5th will be paid a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date is Monday, January 5th. Globe Life’s dividend payout ratio is presently 7.83%.

Wall Street Analysts Forecast Growth

GL has been the topic of several research analyst reports. Morgan Stanley lowered their price target on Globe Life from $179.00 to $177.00 and set an “overweight” rating on the stock in a report on Monday, November 17th. Piper Sandler reissued an “overweight” rating and issued a $167.00 target price on shares of Globe Life in a report on Friday, November 21st. Weiss Ratings restated a “hold (c+)” rating on shares of Globe Life in a research note on Monday. Truist Financial upped their price target on shares of Globe Life from $150.00 to $158.00 and gave the company a “buy” rating in a research report on Friday, October 24th. Finally, Wells Fargo & Company dropped their price objective on shares of Globe Life from $172.00 to $170.00 and set an “overweight” rating on the stock in a report on Friday, October 24th. Seven investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $155.56.

About Globe Life

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.